Parcoten

Parcoten is owned by Consortiun of European and Chinese Investors, headquartered in Multiple (European and Chinese ownership). No. The ultimate owner of Parcoten, Consortiun of European and Chinese Investors, is headquartered in Multiple (European and Chinese ownership), not in the United States.

In 2017, Delorbis became part of a larger consortium involving strategic pharmaceutical investments, although it remains a major Cypriot manufacturer.